Skip to main content
. 2016 Apr 28;7(4):e2209. doi: 10.1038/cddis.2016.102

Figure 2.

Figure 2

CD95high GBM cells co-express known GSC markers. (a) CD95 expression in seven patient tumor samples analyzed by flow cytometry. (be) Co-expression of known GSC markers CD44 (n=7), Integrin α6 (ITGA6; n=7), CD15 (n=3) and CD133 (n=7) within the patient samples (Friedman test). (fk) Correlation of CD95 expression and known GCS markers in the TCGA GBM data set. (n=519 patients, R: Pearson's correlation coefficient, P: probability for no or negative correlation)